Drug Type Small molecule drug |
Synonyms INT 2228, INT2228 |
Target |
Action agonists |
Mechanism FXR agonists(Bile acid receptor FXR agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC29H25F4N3O5S |
InChIKeyVYLOOGHLKSNNEK-UHFFFAOYSA-N |
CAS Registry1383819-10-0 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Liver Cirrhosis | Preclinical | United States | 20 May 2018 | |
| Metabolic Dysfunction Associated Steatohepatitis | Preclinical | United States | 20 May 2018 |





